TY  - GEN 
AU  - Riudavets, Mariona
AU  - Mosquera Martínez, Joaquín
AU  - García Campelo, María del Rosario
AU  - Serra, Jorgina
AU  - Anguera, Georgia
AU  - Gallardo, Pablo
AU  - Sullivan, Ivana
AU  - Barba, Andrés
AU  - Del Carpio, Luís
AU  - Barnadas, Agustí
AU  - Gich, Ignasi
AU  - Majem, Margarita
PY  - 2020
SN  - 2234-943X
UR  - http://hdl.handle.net/20.500.11940/16254
AB  - Background: Immune-related adverse events (irAEs) have been associated with improved efficacy in advanced non-small cell lung cancer (NSCLC) patients receiving anti-PD-(L)1 blockade agents, while the concurrent use of corticosteroids seems to worsen...
TI  - Immune-Related Adverse Events and Corticosteroid Use for Cancer-Related Symptoms Are Associated With Efficacy in Patients With Non-small Cell Lung Cancer Receiving Anti-PD-(L)1 Blockade Agents
DO  - 10.3389/fonc.2020.01677
KW  - CHUAC
VL  - 10.
ER  -